Clinical Trials Logo

Clinical Trial Summary

The purpose of this research study is to see if magnetic resonance imaging (MRI) with a double dose of contrast, or dye, and delayed imaging with MRI can help to diagnose Meniere Disease.


Clinical Trial Description

Meniere's disease (MD) is a medical condition causing attacks of vertigo, ringing in the ears, hearing loss and often a fullness in the ear. Currently there is no definitive test to diagnose the problem. It is believed to be caused by inner ear abnormalities, specifically of an over-collection of lymphatic fluid.The goal of this trial is to determine if an MRI with double dose of IV gadolinium can be diagnostic. ;


Study Design

Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT02371798
Study type Interventional
Source Emory University
Contact
Status Withdrawn
Phase N/A
Start date February 2015
Completion date November 2016

See also
  Status Clinical Trial Phase
Recruiting NCT04835688 - Ventilation Tube Insertion for Unilateral Menière's Disease N/A
Recruiting NCT05851508 - The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease Phase 3
Not yet recruiting NCT05322538 - Menier's Disease - Bone Density Study N/A
Completed NCT05328895 - Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease N/A
Completed NCT04569175 - Non Enhanced Labyrinth Imaging for the Detection of Endolymphatic Hydrops in Meniere's Disease "NELI Study" N/A
Not yet recruiting NCT05582148 - Meniere Disease and Hearing Aids N/A
Completed NCT05844657 - Comprehensive Evaluation in Patients With Meniere's Disease
Completed NCT04902963 - What is the Tympanic Membrane Healing Time After Insertion of a Gelfoam PE Tube? N/A
Completed NCT04686695 - Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Meniere Disease N/A
Recruiting NCT04815187 - Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease Phase 4
Recruiting NCT06278129 - Evaluation of the Diagnostic and Prognostic Efficacy of MRI in Acute Sensorineural Hearing Loss and Ménière's Disease
Recruiting NCT04766853 - Verification of the Efficacy/Safety of the Intratympanic Drug Delivery for Hearing Loss Phase 1/Phase 2
Recruiting NCT04370366 - Imaging of Endolymphatic Hydrops at 7T MRI
Enrolling by invitation NCT03520322 - A Study of a Mastoid Device in Subjects With Ménière's Disease N/A
Not yet recruiting NCT05424302 - Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy N/A
Withdrawn NCT04674735 - Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease Phase 1
Recruiting NCT03795675 - CI Following VS Removal or Labyrinthectomy N/A
Completed NCT04218123 - Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes Phase 2/Phase 3
Completed NCT05960786 - Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand N/A
Terminated NCT02529475 - Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS) Phase 4